| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.60M | 29.89M | 32.64M | 21.37M | 24.46M | 22.79M |
| Gross Profit | 18.18M | 18.50M | 17.21M | 12.26M | 12.40M | 13.95M |
| EBITDA | 4.65M | 6.41M | 6.05M | 3.02M | 2.48M | 3.75M |
| Net Income | 3.15M | 4.94M | 4.04M | 2.12M | 1.70M | 2.77M |
Balance Sheet | ||||||
| Total Assets | 47.81M | 43.86M | 58.74M | 39.74M | 53.89M | 41.85M |
| Cash, Cash Equivalents and Short-Term Investments | 27.25M | 24.38M | 30.72M | 17.16M | 11.43M | 14.24M |
| Total Debt | 1.09M | 961.57K | 1.08M | 221.00K | 200.00K | 277.00K |
| Total Liabilities | 9.41M | 10.93M | 29.24M | 12.40M | 22.00M | 10.97M |
| Stockholders Equity | 38.40M | 32.93M | 29.50M | 27.34M | 31.89M | 30.89M |
Cash Flow | ||||||
| Free Cash Flow | 1.32M | -7.74M | 15.34M | 13.52M | -1.10M | 3.10M |
| Operating Cash Flow | 1.36M | -7.06M | 16.11M | 14.04M | -659.00K | 3.33M |
| Investing Cash Flow | 2.46M | 3.25M | -164.00K | -517.00K | -639.00K | -229.00K |
| Financing Cash Flow | -2.60M | -1.81M | -2.38M | -7.80M | -1.51M | -1.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £78.07M | 54.18 | 2.93% | ― | -3.95% | 16.87% | |
70 Outperform | £475.98M | 71.10 | 1.53% | 1.73% | -0.18% | 11.49% | |
69 Neutral | £92.56M | 152.71 | 4.75% | ― | 0.97% | -71.58% | |
68 Neutral | £174.01M | 37.63 | 5.22% | 0.80% | 22.80% | -32.13% | |
67 Neutral | £137.37M | 11.95 | 8.80% | 1.68% | 6.27% | 0.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £35.65M | -9.99 | 8.83% | 2.44% | -25.63% | -20.36% |